George B Abercrombie - Net Worth and Insider Trading
George B Abercrombie Net Worth
The estimated net worth of George B Abercrombie is at least $6 Million dollars as of 2024-11-13. George B Abercrombie is the Sr. VP & Chief Comm. Officer of Innoviva Inc and owns about 285,479 shares of Innoviva Inc (INVA) stock worth over $6 Million. George B Abercrombie is also the Director of BioCryst Pharmaceuticals Inc and owns about 0 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $0. Details can be seen in George B Abercrombie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George B Abercrombie has not made any transactions after 2022-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of George B Abercrombie
George B Abercrombie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George B Abercrombie owns 5 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Fresh Tracks Therapeutics Inc (FRTX) , and Innoviva Inc (INVA) among others .
Click here to see the complete history of George B Abercrombie’s form 4 insider trades.
Insider Ownership Summary of George B Abercrombie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-04-18 | director |
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | director |
| INVA | Innoviva Inc | 2018-08-21 | Sr. VP & Corp. Partnerships |
 | | 2012-08-07 | director |
| | 2010-04-05 | director |
George B Abercrombie Latest Holdings Summary
George B Abercrombie currently owns a total of 2 stocks. Among these stocks, George B Abercrombie owns 285,479 shares of Innoviva Inc (INVA) as of August 21, 2018, with a value of $6 Million and a weighting of 100%. George B Abercrombie also owns 0 shares of BioCryst Pharmaceuticals Inc (BCRX) as of April 18, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of George B Abercrombie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INVA | Innoviva Inc | 2018-08-21 | 285,479 | 20.32 | 5,800,933 |
| BCRX | BioCryst Pharmaceuticals Inc | 2022-04-18 | 0 | 7.82 | 0 |
Holding Weightings of George B Abercrombie
George B Abercrombie Form 4 Trading Tracker
According to the SEC Form 4 filings, George B Abercrombie has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the sale of 8,000 shares on August 21, 2018, which brought George B Abercrombie around $112,880.
According to the SEC Form 4 filings, George B Abercrombie has made a total of 8 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 5,000 shares on April 18, 2022, which brought George B Abercrombie around $55,200.
Insider Trading History of George B Abercrombie
- 1
George B Abercrombie Trading Performance
GuruFocus tracks the stock performance after each of George B Abercrombie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George B Abercrombie is 54.31%. GuruFocus also compares George B Abercrombie's trading performance to market benchmark return within the same time period. The performance of stocks bought by George B Abercrombie within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George B Abercrombie's insider trading performs compared to the benchmark.
Performance of George B Abercrombie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.8 | | | | | |
| Relative Return to S&P 500(%) | 21.14 | | | | | |
George B Abercrombie Ownership Network
Ownership Network List of George B Abercrombie
Ownership Network Relation of George B Abercrombie
George B Abercrombie Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
George B Abercrombie is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, George B Abercrombie made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
George B Abercrombie Mailing Address
Above is the net worth, insider trading, and ownership report for George B Abercrombie. You might contact George B Abercrombie via mailing address: C/o Inspire Pharmaceuticals, Inc., 4222 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
